Celgene International Sarl NDCs and Package Codes
This page lists NDC package records associated with labeler code 43593 (Celgene International Sarl) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
7
Package NDCs
7
Products
7
Active listings
0
Discontinued
2
Ingredients
0
Therapeutic classes
1
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 7 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| ozanimod hydrochloride .92 mg/1 CAPSULE | 43593-0800-01 | — | On market | View → |
| ozanimod hydrochloride .46 mg/1 CAPSULE | 43593-0801-02 | — | On market | View → |
| ozanimod hydrochloride .23 mg/1 CAPSULE | 43593-0803-03 | — | On market | View → |
| Thalomide Capsule 50 mg/1 CAPSULE | 43593-0205-11 | — | On market | View → |
| Thalomide Capsule 150 mg/1 CAPSULE | 43593-0215-11 | — | On market | View → |
| Thalomide Capsule 200 mg/1 CAPSULE | 43593-0220-11 | — | On market | View → |
| Thalomide Capsule 100 mg/1 CAPSULE | 43593-0210-11 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.